Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel + Cisplatin vs Gemcitabine + Cisplatin in Advanced NSCLC
NCT00173888Phase 2Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jul 2003
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of docetaxel in non-small cell lung cancer (NSCLC) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: 1-year treatment failure rate. Started Jul 2003; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00173888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00173888.